Book Description

How big is the Global Cell & Gene Therapy Drug Delivery Devices market?
According to MarkNtel Advisors study, The Global Cell & Gene Therapy Drug Delivery Devices Market size is projected to grow at a CAGR of around 14% during the forecast period, i.e., 2023-28.

Get Your Hands On to the Free Sample Report (2024-30) – https://www.marknteladvisors.com/query/request-sample/cell-gene-therapy-drug-delivery-devices-market.html

Key Drivers
The factors that are projected to drive the market in the coming years include the following:
Substantial investments in R&D, particularly across the US, for the development of new & improved cell & gene therapies
Mounting prevalence of genetic disorders & chronic diseases
An increasing number of FDA approvals for cell & gene therapies & their clinical trials
Leading Companies in the Global Cell & Gene Therapy Drug Delivery Devices market:
Amgen Inc.
Bausch & Lomb Incorporated
Becton, Dickinson and Company
Bluebird bio Inc.
Castle Creek Biosciences, Inc. (Fibrocell Science, Inc.)
Dendreon Pharmaceuticals LLC
Helixmith Co. Ltd (ViroMed Co., Ltd)
Human Stem Cells Institute
Kite Pharma Inc.
Kolon TissueGene, Inc.
Novartis AG
Orchard Therapeutics plc.
Pfizer Inc.
Renova Therapeutics
Spark Therapeutics Inc.
uniQure N.V.
Vericel Corporation
Explore Full Market Research Report – https://www.marknteladvisors.com/research-library/cell-gene-therapy-drug-delivery-devices-market.html

Global Cell & Gene Therapy Drug Delivery Devices Market Segmentation:
By Product Type

Sub-retinal Injection Cannula
Extension Tube
Intravenous Catheter
Sterile Insulin Syringe
Size 1.0 ML, 31-Gauge Needle
Size 0.5 ML, 22-Gauge Needle
Pre-Filled Syringe
Size 1.0 ML, 22-26 Gauge Needle
Size 4.0 ML, 22-26 Gauge Needle
Infusion Bags
Infusion Bags (Size 10 ML to 50 ML)
Infusion Bags (Size 68 ML)
Infusion Bags (Size 60 ML)
Infusion Bags (Size Up to 65 ML)
By Technology

Microchip Technology
Nano-Technology
Lipid Nanoparticles
By Commercialized Drugs

Luxturna
Kymriah
Yescarta
Zolgensma
Provenge
Strimvelis
Of them all, Luxturna & Yescarta overpowered the Global Cell & Gene Therapy Drug Delivery Devices Market in 2021.

By End-User

Pharmaceuticals & Biotechnology Company
Academic & Research Institute
Hospitals & Clinics
Regional/ Countries Insight:
North America
South America
Europe
Middle East & Africa
Asia-Pacific
Of all the regions, North America attained more than 50% of the revenue share and is anticipated to prevail the same trend in the forecast period.

Note: Should you require specific information beyond the current scope of the report, we are prepared to furnish it as part of our customization services.

To Get Customized Report, Sent Your Enquiry Here - https://www.marknteladvisors.com/query/request-customization/cell-gene-therapy-drug-delivery-devices-market.html

About MarkNtel Advisors:
MarkNtel Advisors is a leading consulting, data analytics, and market research company that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.

For Media Inquiries:
please contact: Phone: +1 628 895 8081, +91 120 4278433

Email: sales@marknteladvisors.com

Corporate Office: Office No.106, H-160, Sector 63, Noida, Uttar Pradesh - 201301, India